ReviewLasers in medical science2025
Could photobiomodulation be used for treatment of rosacea?
Review in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rosacea is a chronic inflammatory disease characterized by facial skin lesions, including flushing, persistent erythema, papules, telangiectasia, and phymatous changes, affecting 5.5% of the world's population. Rosacea causes disfigurement and emotional ramifications and affects quality of life. The pathophysiology of this disease has yet to be understood, and new therapies are necessary. Photobiomodulation has been used to treat dermatological diseases and various conditions, such as inflammatory processes and pain relief. Thus, this study aimed to review studies on PBM for rosacea treatment, summarizing the radiation sources and subject features and reporting the main results. Scientific articles were accessed by PubMed, using keywords related to rosacea and photobiomodulation. Data on irradiation conditions, patient features, experimental models, and results obtained were assessed. The data analysis allowed to list the conditions for applying photobiomodulation that could lead to therapeutic effects, safety, and efficacy in treating the rosacea. Based on clinical and experimental studies accessed, photobiomodulation could decrease rosacea hallmarks and symptoms by decreasing of pro-inflammatory factor expression, inflammatory infiltration and immune cells, and promoting extracellular matrix remodeling. However, due to few studies available on the application of photobiomodulation in the treatment of rosacea, studies based on experimental and clinical models are necessary to better understand the mechanisms of action of this therapy, efficacy, and validation in the treatment of rosacea.
Indexed as
Identifiers
40439755What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.